Does atherosclerosis caused by dialysis limit this treatment?
- PMID: 6348734
Does atherosclerosis caused by dialysis limit this treatment?
Abstract
A retrospective study of 332 dialysis patients (observation period up to 17 years) demonstrated that cardiovascular and cerebrovascular death rates due to atherosclerosis did not increase with length of time on dialysis. Data analysis showed that cardiovascular and cerebrovascular morbidity and mortality during dialysis is primarily caused by high blood pressure existing prior to commencement of dialysis and an unfavourable very low-density lipoprotein/high-density lipoprotein (VLDL/HDL) cholesterol quotient at the beginning of dialysis treatment. The treatment of the patient before acceptance onto dialysis seems therefore to be the determining factor in the prognosis on dialysis.
Similar articles
-
Lipoprotein profile in dialysis and transplant patients.Singapore Med J. 1985 Apr;26(2):193-7. Singapore Med J. 1985. PMID: 3898396 No abstract available.
-
[Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment].Orv Hetil. 1986 May 11;127(19):1129-31. Orv Hetil. 1986. PMID: 3714258 Hungarian. No abstract available.
-
Lipid relation ships in dialysis and renal transplant patients.Q J Med. 1981 Spring;50(198):149-60. Q J Med. 1981. PMID: 7029600
-
[Atherosclerosis and hypertriglyceremia in chronic renal failure].Pol Tyg Lek. 1976 Jun 21;31(25):1089-91. Pol Tyg Lek. 1976. PMID: 181736 Review. Polish. No abstract available.
-
[Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].Lijec Vjesn. 2002 Nov-Dec;124(11-12):372-7. Lijec Vjesn. 2002. PMID: 12679979 Review. Croatian.
Cited by
-
Autonomic dysfunction in uremia assessed by heart rate variability.Pediatr Nephrol. 2003 Nov;18(11):1167-71. doi: 10.1007/s00467-003-1280-4. Epub 2003 Sep 17. Pediatr Nephrol. 2003. PMID: 13680330
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical